Genetic mutations are common in PMEC, and in this case, molecular typing of the lung tumor tissue, adrenal tumor tissue, and plasma samples all revealed the presence of BRAF p.V600E, AKT1, and NFE2L2 mutations. This evidence concerns the gene NFE2L2 and adrenal gland neoplasm.